Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -124,485 | -66,858 | -21,239 | -205,981 | -146,696 |
| Depreciation Amortization | 2,487 | 1,605 | 795 | 5,485 | 2,312 |
| Accounts receivable | -17,725 | -10,466 | -6,352 | -19,726 | -15,340 |
| Accounts payable and accrued liabilities | -33 | -4,083 | -2,698 | -5,617 | -5,679 |
| Other Working Capital | -80,751 | -23,623 | -65,824 | -107,001 | -56,239 |
| Other Operating Activity | 50,725 | 36,540 | 19,313 | 64,281 | 53,170 |
| Operating Cash Flow | $-169,782 | $-66,885 | $-76,005 | $-268,559 | $-168,472 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24,864 | -24,647 | -72 | -974 | -118,837 |
| Purchase Of Investment | -614 | -386 | -10,171 | -118,748 | -723 |
| Sale Of Investment | 28,500 | 22,800 | 4,500 | 101,700 | 59,252 |
| Investing Cash Flow | $3,022 | $-2,233 | $-5,743 | $-18,022 | $-60,308 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,714 | 5,142 | 1,191 | 24,625 | 17,862 |
| Other Financing Activity | 0 | 0 | 0 | 1,280 | 1,280 |
| Financing Cash Flow | $6,714 | $5,142 | $1,191 | $25,905 | $19,142 |
| Beginning Cash Position | 416,804 | 416,804 | 416,804 | 677,480 | 677,480 |
| End Cash Position | 256,758 | 352,828 | 336,247 | 416,804 | 467,842 |
| Net Cash Flow | $-160,046 | $-63,976 | $-80,557 | $-260,676 | $-209,638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -169,782 | -66,885 | -76,005 | -268,559 | -168,472 |
| Capital Expenditure | -24,864 | -24,647 | -72 | -974 | -118,837 |
| Free Cash Flow | -194,646 | -91,532 | -76,077 | -269,533 | -287,309 |